Fairview Health Services turned a $315 million annual loss into a nearly $600 million turnaround in just two years. At the AHA Leadership Summit, CEO James Hereford broke down the strategy behind the comeback, from workforce redesign to frontline-driven process fixes. The post How Fairview Health Services Turned Around a $315M Loss appeared first on…
Now is the time to solve the industry’s identity crisis, and it can only be done through a combination of phishing-resistant and adaptive MFA, fine-grained access control, and standards-based interoperability. The post Healthcare’s Identity Crisis: Why A Single Prescription Requires Multiple Logins appeared first on MedCity News.
In what has become a pattern of spreading vaccine misinformation, the Florida health department is telling older Floridians and others at highest risk from covid-19 to avoid most booster shots, saying they are potentially dangerous. Clinicians and scientists denounced the message as politically fueled scaremongering that also weakens efforts to protect against diseases like measles…
[Sponsored] Too many people sacrifice their quality of life by putting off a surgical procedure. Discover the top-rated hand and wrist surgeons in the Houston area who can help. The post Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust appeared first on MedCity News.
We need to stop blaming those who struggle with addiction and start helping them. Recovery is possible, but only if we’re willing to support each other. Here is one physician’s recovery story. The post From Addiction to Advocacy: A Physician’s Journey to Recovery and Helping Others Heal appeared first on MedCity News.
Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, permitting longer dosing intervals. Lilly plans to apply the technology to its metabolic medicines; the deal follows a similar move Novo Nordisk starting an alliance with Ascendis. The post Following Novo Nordisk, Eli Lilly…
Novo Nordisk is ending its partnership with Hims & Hers due to concerns over its practices related to compounded GLP-1s. The post Why Novo Nordisk Is Dropping Its Collaboration with Hims & Hers appeared first on MedCity News.
Biohaven’s troriluzole, which initially failed a pivotal study in spinocerebellar ataxia, is now being readied for an FDA submission in this rare neurodegenerative disease. The turnabout is based on positive results from a new study that incorporated real-world evidence. The post Real-World Data Salvage Biohaven Drug, Paving Way for FDA Filing in Neuro Disease With…
Tim Winard knew he needed to buy health insurance when he left his management job in manufacturing to launch his own business. It was the first time he had shopped around for coverage, searching for a plan that would cover him and his wife, who was also between jobs at the time. “We were so…
Verily has launched a free consumer health app that aggregates users’ medical records, helps them track their habits and delivers personalized preventive care recommendations. The app also features an AI-powered health assistant that contextualizes users’ data. The post Verily Launches Free Consumer Health App to Put AI-Powered Insights in Users’ Hands appeared first on MedCity…